1-4 of 4
O Kloke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prolonged administration of interferon-alpha in patients with chronic- phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome

Free
DW Beelen, U Graeven, AH Elmaagacli, N Niederle, O Kloke, B Opalka, UW Schaefer
Journal: Blood
Blood (1995) 85 (10): 2981–2990.
https://doi.org/10.1182/blood.V85.10.2981.bloodjournal85102981
Published: 1995
Journal Articles

No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia [letter]

Free
B Opalka, UB Wandl, R Stutenkemper, O Kloke, S Seeber, N Niederle
Journal: Blood
Blood (1992) 80 (7): 1854–1855.
https://doi.org/10.1182/blood.V80.7.1854.1854
Published: 1992
Journal Articles

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma

Free
B Opalka, UB Wandl, R Becher, O Kloke, M Nagel-Hiemke, T Moritz, U Beer, S Seeber, N Niederle
Journal: Blood
Blood (1991) 78 (9): 2188–2193.
https://doi.org/10.1182/blood.V78.9.2188.2188
Published: 1991
Journal Articles

A PvuII polymorphism of the bcr region in patients with hematopoietic disorders and their families

Free
B Opalka, U Wandl, O Kloke, C Oberle, J Koppe, N Niederle, CG Schmidt
Journal: Blood
Blood (1989) 73 (3): 814–817.
https://doi.org/10.1182/blood.V73.3.814.814
Published: 1989